Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Valentini

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Minerva Gastroenterology|July 18, 2020
Groove pancreatitisGiovanni Valentini, Monica Surace, Silvia Grosso, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2007
Enhancement of learning and memory after activation of cerebral Rho GTPasesGiovanni Diana, Giovanni Valentini, Sara Travaglione, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African InfantsNicola Gargano, Lola Madrid, Giovanni Valentini, et al.
Clinical Drug Investigation|August 22, 2015
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisininStephanie E Reuter, Allan M Evans, Sepehr Shakib, et al.
Rays|April 17, 2003
Small bowel diseasesItalo De Vitis, Cristiano Spada, Giuseppe Alessandro Pirozzi, et al.
Scientific Reports|June 8, 2019
Human osteogenic differentiation in Space: proteomic and epigenetic clues to better understand osteoporosisAlessandra Gambacurta, Giulia Merlini, Cristina Ruggiero, et al.
Scientific Reports|January 30, 2019
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval ProlongationChristian Funck-Brentano, Antonella Bacchieri, Giovanni Valentini, et al.
Small Science|January 14, 2026
Polydopamine-Based Antioxidant Countermeasures Against Spaceflight-Induced NeurodegenerationAlessio Carmignani, Attilio Marino, Matteo Battaglini, et al.
Heart Failure Reviews|February 25, 2009
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?Hashim Khan, Marco Metra, John E A Blair, et al.
The American Journal of Cardiology|January 24, 2007
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic functionJalal K Ghali, William B Smith, Guillermo Torre-Amione, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Minerva Gastroenterology|July 18, 2020
Groove pancreatitisGiovanni Valentini, Monica Surace, Silvia Grosso, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2007
Enhancement of learning and memory after activation of cerebral Rho GTPasesGiovanni Diana, Giovanni Valentini, Sara Travaglione, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African InfantsNicola Gargano, Lola Madrid, Giovanni Valentini, et al.
Clinical Drug Investigation|August 22, 2015
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisininStephanie E Reuter, Allan M Evans, Sepehr Shakib, et al.
Rays|April 17, 2003
Small bowel diseasesItalo De Vitis, Cristiano Spada, Giuseppe Alessandro Pirozzi, et al.
Scientific Reports|June 8, 2019
Human osteogenic differentiation in Space: proteomic and epigenetic clues to better understand osteoporosisAlessandra Gambacurta, Giulia Merlini, Cristina Ruggiero, et al.
Scientific Reports|January 30, 2019
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval ProlongationChristian Funck-Brentano, Antonella Bacchieri, Giovanni Valentini, et al.
Small Science|January 14, 2026
Polydopamine-Based Antioxidant Countermeasures Against Spaceflight-Induced NeurodegenerationAlessio Carmignani, Attilio Marino, Matteo Battaglini, et al.
Heart Failure Reviews|February 25, 2009
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?Hashim Khan, Marco Metra, John E A Blair, et al.
The American Journal of Cardiology|January 24, 2007
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic functionJalal K Ghali, William B Smith, Guillermo Torre-Amione, et al.
Pageof 3